Bayer will focus on paying down debt and not make any major acquisitions in the next two or three years, the head of the ...
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
Bayer AG plans to push pause on some of its pharmaceutical dealmaking, focusing instead on reducing the high debt load the ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...
Mit Blick auf die Neuausrichtung der Medikamentenpipeline von Bayer hatte Pharma-Chef Stefan Oelrich im letzten Januar ...
Bayer LeverkusenAfter a shaky start to the season, the German champions have steadied their ship with nine wins in a row ...
Bayer used the Western Canadian Crop Production Show in Saskatoon this week to introduce Prairie farmers to its new FieldView ...
Champions Bayer Leverkusen battled past Mainz 05 with a 1-0 win coming courtesy of a superb Alex Grimaldo free kick on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback